chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received his 1st dose of the Covid19 (Pfizer-Biontech) vaccine in his left arm by myself on June 11, 2021 around 9am at local pharmacy. About 5 minutes later while still being seated in the same seat, Pt started to look like he was going to pass out. His mother tried to keep him engaged and alert by talking to him. I raised his legs to see if it would help. Then, relatively soon after Pt's upper body and face began to shake and he started to foam from the mouth. We lowered him to the ground and placed him on his side. The "seizure" lasted less than 30 seconds. When Pt became alert and aware he stated he just had a "4 hour dream". When the paramedics arrived 5  minutes later we had Pt seated in a chair again and he had drank some water. About 5-10 minutes later he began to feel nauseated  and vomited. The paramedics transported Pt to the hospital.
he tested positive for COVID; he tested positive for COVID; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs) from a contactable physician (patient). A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on the right deltoid on 28Dec2020 09:30 at single dose for COVID-19 immunization. Medical history included diabetic (he is a diabetic, but he is not on medication for it) from Nov2018 and ongoing, hepatitis (not ongoing) (He had hepatitis virus for 15 to 20 years. It resolved 5 or 6 years ago. It corrected on it's own), supplement, hypertension and carcinoma of the lung. Everyone in his family has hypertension. His sister had carcinoma of the lung. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. The patient did not have additional vaccines administered on same date of the Pfizer suspect. There were no prior vaccinations within 4 weeks. There were no adverse events following prior vaccinations. Concomitant medication included doxazosin mesilate (CARDURA), bisoprolol fumarate, hydrochlorothiazide (ZIAC), nystatin (STATIN) taken for lipids, colecalciferol (VITAMIN D) taken for supplement, fish oil, acetylsalicylic acid (BABY ASPIRIN), vitamin C [ascorbic acid]. The patient also received multivitamin. He has been on all concomitant medications for at least three to four years. The patient was scheduled for the next dose on 18Jan2021. On 05Jan2021 he tested positive for COVID. The event was reported as serious as medically significant. The patient was given the antibody infusion and steroid injection. It was outpatient. He was not admitted. Treatment was received for the events. The outcome of the events was unknown.  Information on lot number/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. However individuals may not be protected until at least 7 days after their second dose of the vaccine.
not much sore ness from the shot at all.  on the 1-11-2021 I felt a little flue like symptoms. head ace, low temp 97degres, aches in shoulders, small lymph node under left arm solen ,  I went to bed and the next morning it was gone. Tonight I feel a little of the aches.  not bad but wanted you to know.   Im ready for the next shot on the 1-28-2021.
Headache, dizziness, fast heart rate. All but headache passed within 15 minutes so did not recognize it was related or report it. On Thursday evening developed itch, redness, swelling and warmth to touch at injection site. Called RN who reassured this was a common side effect though delayed.
Client received 2nd dose of Pfizer today, but 1st dose was Moderna on 01/13/21.
This spontaneous report was received from a dentist regarding his wife: a 72 year old female patient with penicillin allergy and DEMEROL allergy. Patient had no pertinent medical history. On an unknown date in November 2010, the patient was vaccinated with a dose of live ZOSTAVAX (lot#, dose, route not reported). Concomitant medications included: influenza virus vaccine (manufacturer unknown). On an unknown date in November 2010, the patient developed cataract, malaise, neck pain, headaches, rash and rosacea after receiving a dose of live ZOSTAVAX. The patient had a surgery for the cataract. Treatment included antihistamines, antiviral, MEDROL and creams (unspecified). Extensive laboratory tests were performed. The patient sought medical attention(saw the physician). The outcome of cataract, malaise, neck pain, headaches, rash and rosacea was reported was not recovered. The relatedness for cataract, malaise, neck pain, headaches, rash and rosacea was unknown for live ZOSTAVAX. This is 1 of 2 reports received from the same reporter. Additional information has been requested.
1st shot lot 016m20A sore arm and weird rash on arm  2nd shot lot 032m20A weird rash on chest with malaise- extended
Onset 10-12 hours after dose on 1/18/21 Body aches, chills awakening from sleep. Fever 100.5 after acetaminophen. Weakness, dizziness, mild Pre-syncope, nausea. Persisted through the night and early morning and gradually improving the next day. 24 hours after symptom onset, temp was still 99.5. Much improved with residual generalize muscle soreness upon awakening on 1/20/21
This case was reported by a healthcare professional and described the occurrence of arm swelling (injection site) in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Previous and/or concurrent vaccination included MMR; manufacturer unspecified given on the same unspecified date as KINRIX; measles and varicella virus vaccine; manufacturer unspecified given on the same unspecified date as KINRIX. On an unspecified date the subject received 1st dose of KINRIX (unknown). At an unspecified time after vaccination with KINRIX, the subject experienced arm swelling (injection site). A sales representative reported that a public health nurse stated that she gave ten doses of KINRIX and out of these doses, seven children or their parents reported significant swelling in the arm where they were injected. All of the children were within the four to six years age range. She stated that she gave KINRIX on one arm and a MMR vaccine and Varicella vaccine on the other arm. Please see A0780868A, A0780875A, A0780876A, A0780877A, A0780879A and A0780880A for the six additional cases reported by the nurse. At the time of reporting the event was resolved. The healthcare professional considered the event was probably related to vaccination with KINRIX.
Extreme dizziness, hard to focus or walk. I know dizziness was mentioned in the handout, but this is rough!
trouble urinating (painful); achy feeling like flu; headache; sweating like a dog; Cold sweats; trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating like a dog), COLD SWEAT (Cold sweats), DYSPNOEA (trouble breathing), DYSURIA (trouble urinating (painful)) and MYALGIA (achy feeling like flu) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 014M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced HYPERHIDROSIS (sweating like a dog), COLD SWEAT (Cold sweats), DYSPNOEA (trouble breathing), MYALGIA (achy feeling like flu) and HEADACHE (headache). On an unknown date, the patient experienced DYSURIA (trouble urinating (painful)). At the time of the report, HYPERHIDROSIS (sweating like a dog), COLD SWEAT (Cold sweats), DYSPNOEA (trouble breathing), DYSURIA (trouble urinating (painful)) and MYALGIA (achy feeling like flu) outcome was unknown and HEADACHE (headache) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include diabetes medication,high blood pressure medication. Treatment information was not provided. Patient having kidney infection two and half months ago and was prescribed antibiotics, but pain was started again. Also patient has only one kidney as the other was removed  several years ago. Patient stated at the time of call temperature was 95.
no adverse effect; administered improperly stored vaccine; This spontaneous report was received from a medical assistant referring to refers to a 6-month-old female patient. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not reported.  On 15-OCT-2019, the patient was inadvertently administered improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # R026541 with expiration date: 11-JUL-2020) (strength, exact dose, route of administration and anatomical location were not reported) for prophylaxis. Administered dose of vaccine experienced a temperature excursion of 51.62 degrees Fahrenheit for 10 hours. It was reported that digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. There were no adverse effects reported. No product quality complaint (PQC) was involved.  This is one of the several reports received from the same reporter.
1 of 2 pts vaxed from the same lot who devel erythema, induration & swelling @ inj site & fever (unmeasured);this pt had 1 10cm area of induration, marked swelling of thith;unable to walk w/o marked limp;tx w/APAP & warm compresses
report soreness at the injection started on 01/06/21 at 5:pm and today she began with achiness and headache with no fever which she states is tolerable at this time.  There was no home remedies. continues to work and  She will continue to monitor symptoms
Patient diagnosed with SIRVA by  physician. Pt claims to have pain and reduced utilization of left arm.
had some back pain; had soreness, felt achy; regular injection pain, achy after 2nd dose; had little bit chills; patient woke up and urinated in morning the urine was dark; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (patient woke up and urinated in morning the urine was dark), BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 010M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHROMATURIA (patient woke up and urinated in morning the urine was dark). On an unknown date, the patient experienced BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills). At the time of the report, CHROMATURIA (patient woke up and urinated in morning the urine was dark), BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Urine analysis: normal (normal) Blood in urine, but no signs or abnormal lab values which indicated infection.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-392285 (Patient Link).
Patient was lethargic, poor appetite, vomiting x 3-4 times.
No Adverse events, Patient got Moderna  first shot on April 02 and didn't mention when getting the Johnson vaccine
Headache, Myalgia, NauseaVomiting, chills, fatigue;  Narrative:
COVID arm. Raised itchy rash local to injection site developed 8 days after injection. Roughly circular, diameter 1.5-2 inches.
Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/27/2022 Discharge Date: 10/29/2022  HOSPITAL COURSE:   Patient is a 75 y.o. female presented to the emergency department due to acute on chronic weakness.  She was initially diagnosed with COVID on 10/25/2022 and was discharged home, however, she re-presented on 10/20 07/2022 with generalized weakness and feeling like she was going to faint at home.  She also endorsed cough, sore throat, shortness of breath.  At the time presentation to the emergency department she was afebrile with vital signs remarkable for tachypnea at 20 breaths per minute.  She remained on room air.Chest x-ray imaging revealed no acute cardiopulmonary process.  Lbs demonstrated creatinine of 1.26 consistent with baseline renal dysfunction.  Complete blood count with diff without leukocytosis. Urinalysis is positive for nitrites, moderate leukocytes with 23.2 white blood cells and many bacteria.  She is given a dose of antibiotics  and admitted to floor.     Urine cultures demonstrated E coli. She was subsequently treated with Rocephin x2 doses while inpatient and transitioned to oral Keflex for a total of 5 day course of antibiotics.  She remained relatively asymptomatic and on room air from a COVID standpoint.  She was not starting on Paxlovid due to interactions with other medications.  She was not a candidate for steroids or remdesivir.  PT / OT evaluated and home with home health care.  She became stronger and closer to physical baseline prior to discharge.  She was discharged on 10/29/2022 in stable and improved condition with the remainder of oral Keflex to complete 5 days of antibiotics for urinary tract infection.  She will be receiving home health care through Home Healthcare who could provide skilled nursing as well as PT and OT services.
Had flu shot, DTap, HiB at primary care appt @ 1330. Felt warm around 7pm. mom gave tylenol. Mom noted "seizure like activity" around 8pm. Mom called 911. Transported to ED. Child was given Ibuprofen at ED and sent home w/ parent. Child had F/u Appt w/ pediatrician on 2/18/20. VAERS reports requested by Dr.
About 5 hours after influenza shot, temp dropped and then developed a fever about 102 degrees F, body trembling for 2 hours, body ache, headache, "extreme flu symptoms". Still sick next day, but following day, ok, just a headache. No Dr visit.
44hrs after the second dose I went out to run and noticed my hands felt cold the entire time. Never took my gloves off which is unusual. My hands felt strange too. Once home, took off my gloves to see my hands where dead white. They truly looked as I found I were dead. No color at all just white. They felt oddly tingling and numb. I got in the hot shower and watched as the color very very slowly started to come back. It took a solid 45min to and hour for full color. Since that time when my hands have gotten cold or my core temp is cold I notice the same phenomenon happening, I went to my doc and she confirmed Raynaud?s phenomena.
Initial symptoms at 12hr post-vaccine typical chills  & aches & nausea.; duration 6 hr. At 24hr mark, chest pains started with palpitations. Worse with exertion. Subsided and returned. Sought treatment at 48hr post-vaccine. Clear ekg, chest xray, and chest ct. Aspirin 325mg calmed the symptoms.
Moderna Covd-19 Vaccine EUA Severe spinal pain for 48 hours.  After 48 hours became a dull pain.  Within 12-13 hours of shot caused insomnia and flashes of feeling I was burning from the inside out.  The worst of the side effects by far was the several spinal pain.  I took no medication.  I rested in bed.
I received the Shingles (Shingrix 50MCG/0.5 ML) and Pneumonia (Pneumovax 23MCG/0.5ML) injections at a local pharmacy, both in my left arm, around noon on 10/31/2020. About 6pm that evening I started having body aches, fever, chills, and rash on left arm. Fever, horrible body aches and chills lasted 43 hours, with the fever peaking at 102.1. I consulted via phone with my family doctor, on 11/7/202 0, who had me come to her office where they performed a COVID19 Rapid test as  well as the one that takes up to three days to get results. The Rapid test results were negative. She recommended I report my reaction to pharmacy. They recommend I report my reaction to your organization.
Redness, rash 3.5 inches, and itching surrounding injection site. Warm to the touch and slight swelling. Light redness day two around injection site day after vaccine. Reappeared worse, larger and more red one week after injection.
shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2019, the patient received the 1st dose of Shingrix. On 14th May 2019, less than a year after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st dose of shingrix the middle of January 2019. On 14th May 2019, the patient was diagnosed with shingles. The patient asked when should get 2nd dose of shingrix.
administration of Varivax to her daughter-in-law that is 12 weeks pregnant; soreness in right arm due to administration of vaccine; This spontaneous prospective pregnancy report was received from a patient's mother-in-law and refers to a 34-year-old female patient. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported. The patient's medical history included chickenpox. She became pregnant with last menstrual period (LMP) of 06-JAN-2021 and estimated due date (EDD) of 12-OCT-2021.  On 25-MAR-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) in the right deltoid, for prophylaxis (lot # T028304 was verified to be valid, expiration date reported and established as 20-AUG-2022), (dose and route of administration were not provided). On the same day, the patient was also vaccinated with an unspecified influenza virus vaccine (reported as flu vaccine) in the right deltoid (strength, dose, frequency, route of administration, indication, lot number and expiration date were not provided).  Initial exposure to varicella virus vaccine live (oka/merck) (VARIVAX) and the flu vaccine was at 11 weeks. The pregnancy outcome was pending. The reporter stated that the patient checked the box indicating that she was pregnant on her paperwork. The patient's provider was notified and informed of the administration of varicella virus vaccine live (oka/merck) (VARIVAX). The patient was informed that her pregnancy would be continually monitored. On an unknown date in March 2021, the patient experienced also soreness in her right arm. The patient did not seek medical attention and there was no treatment given for the event. The outcome of the event was unknown.  The reporter considered vaccination site pain to be related to the suspect vaccines (reported as "due to administration of vaccines").
Excessive rash over most of the body. Swelling of glands under the arms and groin area. Vision problems, very irritating when exposed to sunlight or electrical lights. Vision worsened in right eye from 20/30 to 20/200 within 5 months.  Smallpox: all deporting shots to leave country was given on 08/06. Knowledge of all-unknown.  I had a reaction to a vaccination for smallpox while I was in the military.  It was given to me by medics on 08/06/1970.  Symptoms were swelling, pain, temperature, splotch type rash, itchy and watery eyes. I was treated for the swelling and rash first. After 4 days of treatment for these problems I was then refined to quarters with no use of any type of light-just total darkness for 2 days. Eventually all the rash and swelling went away. At this time I acknowledged to the military that I was having vision problems. There was no available optometrist at the base where I was stationed. I came home in 09/1970.  I then was sent to another country. Between 10/1970 and 01/1971 I noticed a distinct problem with having to squint all the time because the sun or bright lights hurt my eyes severely. At this time I went to the optometrist and found my eye sight to be 20/100 already. By 02/1971 my eye sight had gone to 20/200. This being in my right eye only.  My left eye is still 20/20. Glasses were issued by the military at this time. By 975 glasses for the vision in the right eye could not be fitted. I'm blind in this eye today. I never filed a complaint to the military until 02/02.  I have talked to numerous optomologists and optometrists and they suggest or agree that I may have a weak or weaker eye, being the right eye. This is all after fact or a matter of opinion. If there is any information available on the effects of a reaction to Smallpox vaccination that could have caused this problem I would greatly appreciate hearing about it. I would like to hear a response on this or advise on what you think.
started vomiting about 1 1/2 hrs p/vax cont until later afternoon the next day; had low grade fever during that time; went to clinic 10AUG93 had dx of viral infection;
accidentally gave another brand of men b for second dose; This case was reported by a consumer via interactive digital media and described the occurrence of interchange of vaccine products in a male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and MENINGOCOCCAL B VACCINE for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero, Bexsero Pre-Filled Syringe Device and the 2nd dose of MENINGOCOCCAL B VACCINE. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced interchange of vaccine products. On an unknown date, the outcome of the interchange of vaccine products was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 22-JUN-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The reporter stated that their son's doctor accidentally gave him another brand of Meningococcal B for his 2nd dose. The reporter enquired duration to get the Bexsero 2nd dose and was it safe. Additional Supportive Information: The patient received Bexsero followed by Meningococcal B vaccine other brand, which led to interchange of vaccine products. No follow-up was possible as no contact details were available.